SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001140361-24-010651
Filing Date
2024-03-01
Accepted
2024-03-01 08:53:22
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC14D9C ny20021737x5_sc14d9.htm SC14D9C 15771
2 EXHIBIT 99.1 ny20021737x5_ex99-1.htm EX-99.1 19487
3 ny200201737x5_logo1.jpg GRAPHIC 593562
4 ny200201737x5_logo2.jpg GRAPHIC 394421
  Complete submission text file 0001140361-24-010651.txt   1397530
Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Filed by) CIK: 0001797768 (see all company filings)

IRS No.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Subject) CIK: 0001797768 (see all company filings)

IRS No.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-91893 | Film No.: 24707137
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)